Azimut Exploration Inc. press release
IIROC Trading Halt - BLU
TSXV - TSX Venture Exchange · Gold · Silver · Copper · Zinc · Antimony · Lithium · Cesium · Rubidium · Gallium · Tin · Nickel · Platinum · Palladium · Platinum Group Metals · Cobalt · Molybdenum · Rare Earth Elements · Tungsten · Canada
Canada NewsWire
TORONTO, Dec. 11, 2018
TORONTO, Dec. 11, 2018/CNW/ - The following issues have been halted by IIROC:
Company: BELLUS Health Inc.
TSX Symbol: BLU
Reason: Dissemination
Halt Time (ET): 09:33
IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.
SOURCE Investment Industry Regulatory Organization of Canada(IIROC) - Halts/Resumptions
View original content: http://www.newswire.ca/en/releases/archive/December2018/11/c4529.html
IIROC Inquiries 1-877-442-4322 (Option 2) - Please note that IIROC is not able to provide any additional information regarding a specific trading halt. Information is limited to general enquiries only.Copyright CNW Group 2018
Earlier from Azimut Exploration Inc.
- Today's Research Reports on TSO3, Emerald Health Therapeutics, Emblem and BELLUS Health
- BELLUS Health Updates BLU-5937 Top-Line Phase 1 Results Timeline to November 2018
- BELLUS Health Announces Issuance of New U.S. Patent Claiming P2X3 Selectivity as a Means of Minimizing Taste Effects for its Lead Chronic Cough Drug Candidate BLU-5937